GlaxoSmithKline Pharmaceuticals Limited — Results, 14-02-2025: Integrated Filing- Financial

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting regarding the integrated financial results for the quarter and nine months ended December 31, 2024. The company reported a revenue from operations of ₹946.36 crore for the quarter, showing a year-on-year increase from ₹804.98 crore during the corresponding period in 2023. Profit before tax for the quarter stood at ₹30.64 crore, significantly improving from ₹6.51 crore in the previous year. The board also declared a special interim dividend of ₹12 per share. This solid financial performance could enhance investor sentiment, indicating a positive outlook amidst recovery trends in the pharmaceutical sector.